News Center

位置：

Honors Announcement

Group News

Media Reports

Group Holds 2020 Policy and Goal Announcement Conference

Category:

Group News

发布时间：2020-01-18

【概要描述】 Hard work and entrepreneurship go hand in hand, and pragmatic action drives development. On December 30, 2019, Shisiyao Group solemnly held the “2020 Policy and Goal Launch Conference.”

Group Holds 2020 Policy and Goal Announcement Conference

Hard work and entrepreneurship go hand in hand, and earnest, pragmatic efforts drive common development. On December 30, 2019, Shisiyao Group solemnly convened the “2020 Policy and Goal Launch Conference.” Chairman Qu Jiguang, together with nearly 200 mid- and senior-level managers from various subsidiaries—including Shiyao, Hebei Guangxiang Pharmaceutical, Jiangsu Bosheng Medical New Materials, and Hebei Hanlin Technology—gathered to jointly map out the Group’s grand blueprint for future growth. The meeting was chaired by Shi Jianhui, Secretary of the Company’s Party Committee.

This conference has undergone significant reforms and adjustments in its presentation format, the individuals delivering the announcements, the content of the announcements, and the order in which they are presented. Specifically, announcements will now be made by decision-makers and management at all levels of the Group, with the aim of cultivating the next generation of leaders, strengthening hierarchical management and talent pipeline development, and energizing and inspiring managers at all levels to demonstrate a strong work ethic, unwavering dedication, and a proactive spirit—thus enabling them to assume the critical responsibilities and missions facing the company today and in the future.

At the meeting, Chairman Su Xuejun first delivered a work report on the formulation of the 2020 guiding principles and objectives. Subsequently, decision-makers and management at all levels of the Group presented and committed to specific measures and timelines for implementing these principles and objectives in their respective areas of responsibility.

After hearing the presentation of policies and objectives from each subsidiary, Chairman Qu Jiguang provided focused commentary on the work reports submitted by the various departments and delivered a speech. He noted that in 2019, despite a profoundly changing market environment characterized by adjustments to medical insurance policies, the evaluation of generic drug consistency, volume-based procurement, and other significant developments, the Group, under the leadership of its Board of Directors, successfully overcame the severe challenges arising from the overlapping impacts of economic transformation and structural issues, thereby achieving its targeted business objectives for the year and ushering the enterprise into a new phase of high-quality development.

He pointed out that, at a critical juncture in the enterprise’s drive for high-quality development, a major restructuring of the Group’s Board of Directors and management team has been put in place, thereby entrusting the Board and all levels of management with more ambitious development goals and greater responsibilities. In the face of this new development landscape and set of objectives, the younger generation must adopt entirely new business philosophies and a more competitive stance, carry forward the struggle, and rise to the dual challenges posed by both the product market and the capital market.

To ensure the Group’s success in the coming year and beyond, he made the following requirements: First, fully recognize the current severe economic situation, strengthen our sense of urgency and crisis regarding development, and firmly uphold our conviction of ultimate success. Second, in the face of a complex and challenging market environment, we must summon the courage to make tough, decisive reforms—undertaking bold internal restructuring, deepening enterprise-wide reform, unleashing endogenous momentum, streamlining management hierarchies, enhancing managerial efficiency, institutionalizing sound management practices, and delivering tangible results. Third, we must focus reform efforts on the effective implementation of next year’s policies and objectives; all subsidiaries are required to sign accountability agreements with the Group, leaving no room for compromise, no exceptions, and no favoritism, and sparing no effort to ensure that next year’s business targets are met in full and without deviation. Fourth, we must reinforce incentive and constraint mechanisms to guarantee that all tasks are carried out in a solid and effective manner.

With the long journey ahead and the winds at our backs, we will once again stand boldly at the crest of the tide. The conference called for unwavering commitment to the Group’s clearly defined policies and objectives for 2020: continuously recognizing, grasping, and leading the new normal; taking the new development philosophy as our guiding principle; and making supply-side structural reform the central task—thus steering the enterprise toward higher quality, greater efficiency, and more sustainable growth. Our mission demands responsibility; our mission charts the course for the future. Let us unite as one, strive with all our might, seize every moment, cherish the prime of our lives, and write a glorious new chapter in the Group’s development in the new era.

Keywords:

Unite as one and work hard!

Flu Season Strikes: Shisi Pharmaceutical’s Arbidol Joins the Frontline of Flu Prevention

Unite as one and work hard!

Flu Season Strikes: Shisi Pharmaceutical’s Arbidol Joins the Frontline of Flu Prevention